Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's Syndrome
Status:
RECRUITING
Trial end date:
2025-02-17
Target enrollment:
Participant gender:
Summary
Drug interventional, controlled, randomized open-label, parallel-group, multicenter study in patients with bilateral adrenal incidentalomas associated with subclinical Cushing's syndrome
Phase:
PHASE4
Details
Lead Sponsor:
IRCCS Azienda Ospedaliero-Universitaria di Bologna